Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-06-000814
Filing Date
2006-12-07
Accepted
2006-12-07 18:00:23
Documents
1
Period of Report
2006-12-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3825
  Complete submission text file 0001079973-06-000814.txt   5885
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8400 E PRENTICE AVENUE GREENWOOD VILLAGE CO 80111
Business Address 8400 E PRENTICE AVENUE GREENWOOD VILLAGE CO 80111 303-694-1300
Roaring Fork Capital SBIC, L.P. (Reporting) CIK: 0001310175 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50019 | Film No.: 061263712